We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+3.98%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$29.9B
AUM Growth
+$1.03B
Cap. Flow
+$181M
Cap. Flow %
0.61%
Top 10 Hldgs %
19.41%
Holding
1,859
New
106
Increased
777
Reduced
753
Closed
113

Top Buys

Rank Stock Value
1
PM icon
Philip Morris
PM
+$174M
2
DOC icon
Healthpeak Properties
DOC
+$98.8M
3
WMB icon
Williams Companies
WMB
+$71.3M
4
AMZN icon
Amazon
AMZN
+$61.5M
5
VTR icon
Ventas
VTR
+$61.1M

Sector Composition

Rank Sector Weight
1 Healthcare 17.15%
2 Consumer Staples 12.29%
3 Energy 10.19%
4 Financials 9.17%
5 Industrials 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITW icon
1226
Illinois Tool Works
ITW
$76.5B
$818K ﹤0.01%
10,068
-3,753
-27% -$304K
SCHL icon
1227
Scholastic
SCHL
$661M
$794K ﹤0.01%
23,038
-1,214
-5% -$41.4K
STZ icon
1228
Constellation Brands
STZ
$21.1B
$791K ﹤0.01%
9,310
-638
-6% -$50.7K
INSY
1229
DELISTED
Insys Therapeutics, Inc.
INSY
$789K ﹤0.01%
38,068
-11,438
-23% -$227K
ED icon
1230
Consolidated Edison
ED
$38.9B
$778K ﹤0.01%
14,507
-6,059
-29% -$329K
TSLA icon
1231
Tesla
TSLA
$1.41T
$776K ﹤0.01%
55,875
-26,505
-32% -$355K
TAL
1232
DELISTED
TAL INTERNATIONAL GROUP, INC.
TAL
$769K ﹤0.01%
17,938
-386
-2% -$17.2K
CME icon
1233
CME Group
CME
$98.9B
$764K ﹤0.01%
10,321
-1,179
-10% -$88.9K
LGND icon
1234
Ligand Pharmaceuticals
LGND
$5.52B
$761K ﹤0.01%
18,136
+16,091
+787% +$671K
SAFM
1235
DELISTED
Sanderson Farms Inc
SAFM
$761K ﹤0.01%
9,693
+1,365
+16% +$102K
DTE icon
1236
DTE Energy
DTE
$27.1B
$760K ﹤0.01%
12,020
-112,058
-90% -$6.6M
WCC
1237
WESCO International
WCC
$16.3B
$759K ﹤0.01%
9,115
+8,949
+5,391% +$767K
HBAN icon
1238
Huntington Bancshares
HBAN
$33.8B
$754K ﹤0.01%
75,578
-1,218,756
-94% -$11.6M
CNXN icon
1239
PC Connection
CNXN
$2.15B
$748K ﹤0.01%
36,821
+21,321
+138% +$460K
ACET
1240
DELISTED
Aceto Corp
ACET
$735K ﹤0.01%
36,602
+25,641
+234% +$523K
CMD
1241
DELISTED
Cantel Medical Corporation
CMD
$732K ﹤0.01%
21,703
-1,260
-5% -$41.6K
PROV icon
1242
Provident Financial
PROV
$116M
$725K ﹤0.01%
47,037
-3,619
-7% -$54.9K
QGENF
1243
DELISTED
QIAGEN NV
QGENF
$725K ﹤0.01%
34,400
+33,920
+7,067% +$715K
PH icon
1244
Parker-Hannifin
PH
$117B
$720K ﹤0.01%
6,014
-287
-5% -$34.4K
SHOR
1245
DELISTED
ShoreTel, Inc.
SHOR
$717K ﹤0.01%
83,367
-211,458
-72% -$1.82M
NLSN
1246
DELISTED
Nielsen Holdings plc
NLSN
$717K ﹤0.01%
16,062
+888
+6% +$39.7K
ITG
1247
DELISTED
Investment Technology Group Inc
ITG
$716K ﹤0.01%
+35,423
New +$639K
COLM icon
1248
Columbia Sportswear
COLM
$2.89B
$711K ﹤0.01%
17,196
+1,982
+13% +$79K
PLXS icon
1249
Plexus
PLXS
$6.36B
$710K ﹤0.01%
17,722
-2,401
-12% -$98K
FRX
1250
DELISTED
FOREST LABORATORIES INC
FRX
$707K ﹤0.01%
7,664
-7,175
-48% -$579K

Similar funds

Federated Hermes's Q1 2014 Portfolio in Review

As of Q1 2014, Federated Hermes held 1,859 positions worth $29.9B, up 3.6% from $28.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Federated Hermes's Q1 2014 filing shows 106 new, 777 increased, 753 reduced and 113 closed positions. Its largest new stake was Colony Capital, Inc.: 1,465,448 shares worth $32.2M. The largest sale was AbbVie, an estimated $210M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 17% a quarter earlier, followed by Consumer Staples and Energy.

  • Federated Hermes's largest Q1 2014 buy was Colony Capital, Inc.: 1,465,448 shares worth $32.2M.
  • Federated Hermes added most to Philip Morris in Q1 2014, an estimated $174M increase.
  • Federated Hermes's biggest Q1 2014 reduction was AbbVie, cutting an estimated $210M.
  • Federated Hermes fully exited Sinclair Inc in Q1 2014, selling an estimated $36.1M.
  • Federated Hermes's ten largest holdings make up 19% of its $29.9B portfolio in Q1 2014.
  • Federated Hermes opened 106 new positions and closed 113 in Q1 2014.
  • Federated Hermes's portfolio value rose 3.6% quarter-over-quarter to $29.9B.

Based on Federated Hermes's 13F filing for Q1 2014, filed 6 May 2014.